7-131504383-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001018111.3(PODXL):c.1605G>T(p.Gly535=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00335 in 1,614,162 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 47 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 67 hom. )
Consequence
PODXL
NM_001018111.3 synonymous
NM_001018111.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.407
Genes affected
PODXL (HGNC:9171): (podocalyxin like) This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 7-131504383-C-A is Benign according to our data. Variant chr7-131504383-C-A is described in ClinVar as [Benign]. Clinvar id is 786111.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.407 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0517 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PODXL | NM_001018111.3 | c.1605G>T | p.Gly535= | synonymous_variant | 9/9 | ENST00000378555.8 | |
PODXL | NM_005397.4 | c.1509G>T | p.Gly503= | synonymous_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PODXL | ENST00000378555.8 | c.1605G>T | p.Gly535= | synonymous_variant | 9/9 | 1 | NM_001018111.3 | P2 | |
PODXL | ENST00000322985.9 | c.1509G>T | p.Gly503= | synonymous_variant | 8/8 | 1 | A2 | ||
PODXL | ENST00000484346.1 | n.364G>T | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
PODXL | ENST00000446198.5 | c.*870G>T | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0161 AC: 2455AN: 152168Hom.: 47 Cov.: 32
GnomAD3 genomes
AF:
AC:
2455
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00467 AC: 1174AN: 251474Hom.: 26 AF XY: 0.00349 AC XY: 474AN XY: 135912
GnomAD3 exomes
AF:
AC:
1174
AN:
251474
Hom.:
AF XY:
AC XY:
474
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00202 AC: 2947AN: 1461876Hom.: 67 Cov.: 31 AF XY: 0.00180 AC XY: 1306AN XY: 727242
GnomAD4 exome
AF:
AC:
2947
AN:
1461876
Hom.:
Cov.:
31
AF XY:
AC XY:
1306
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0161 AC: 2455AN: 152286Hom.: 47 Cov.: 32 AF XY: 0.0156 AC XY: 1165AN XY: 74468
GnomAD4 genome
AF:
AC:
2455
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
1165
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at